DENVER BUSINESS JOURNAL - Venaxis Inc., a Castle Rock medical device company, said it's acquired BiOptix Diagnostics Inc. of Boulder.
Venaxis (Nasdaq: APPY) said in a Securities and Exchange Commission filing that it's paying "627,010 shares of Venaxis common stock with an aggregate value of $1,950,000" for BiOptix.
BiOptix uses technology developed by Dr. John 'Jan' Hall, a professor at the University of Colorado, who shared the Nobel Prize for Physics in 2005.
"The newly combined company will benefit from BiOptix technology and market opportunity, combined with Venaxis resources and public listing," said Steve Lundy, CEO of Venaxis, in a statement.
Read more at the Denver Business Journal: http://bit.ly/2cVupjk
Copyright 2016 Denver Business Journal